• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜色素变性患者中明视微视野相关参数的重测变异性:重复研究报告第2号。

Test-retest variability of mesopic microperimetry-associated parameters in patients with retinitis pigmentosa: REPEAT Study Report No. 2.

作者信息

Karuntu Jessica S, Pfau Maximilian, Jolly Jasleen K, Boon Camiel J F

机构信息

Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.

Institute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland.

出版信息

Acta Ophthalmol. 2025 May;103(3):313-326. doi: 10.1111/aos.16780. Epub 2024 Nov 24.

DOI:10.1111/aos.16780
PMID:39581886
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11986405/
Abstract

PURPOSE

Understanding test-retest variability (TRV) of mesopic microperimetry is critical for defining meaningful treatment effects in retinitis pigmentosa (RP) trials. This study uniquely evaluates intra- and intervisit TRV and coefficients of repeatability (CoRs) for microperimetry parameters in RP patients with varying best-corrected visual acuity (BCVA) levels.

METHODS

In this single-centre prospective cohort study, RP patients were assessed on two visits, 14.0 days apart. Patients were grouped by BCVA: low (≤20/50 Snellen; ≥0.4 logMAR) or moderate (>20/50 Snellen; <0.4 logMAR). Using Bland-Altman analyses, the CoRs for intra- and intervisit variability were determined for pointwise (dB), mean (dB), and volume sensitivity (dB*deg) on mesopic microperimetry.

RESULTS

Intravisit CoRs for mean, volume, and pointwise sensitivity were 1.7 dB, 353.2 dBdeg, and 8.6 dB, respectively, in the low-BCVA group (n = 32), and 0.9 dB, 254.5 dBdeg, and 7.3 dB in the moderate-BCVA group (n = 15). Intervisit CoRs for mean, volume, and pointwise sensitivity were 2.4 dB, 355.2 dBdeg, and 10.2 dB in the low-BCVA group (n = 31). The moderate-BCVA group (n = 16) showed smaller CoRs of 1.6 dB, 386.8 dBdeg, and 7.7 dB for mean, volume, and pointwise sensitivity. BCVA and mean sensitivity, but not fixation stability, are predictors of TRV for volume sensitivity.

CONCLUSIONS

Due to significant TRV, pointwise sensitivity is an unreliable endpoint for RP patients, irrespective of BCVA. Mean sensitivity is suitable as an endpoint when BCVA is relatively preserved. Volume sensitivity provides additional spatial information, and shows promise as a clinical endpoint for assessing macular sensitivity changes on mesopic microperimetry in patients with RP.

摘要

目的

了解中视微视野检查的重测变异性(TRV)对于在视网膜色素变性(RP)试验中定义有意义的治疗效果至关重要。本研究独特地评估了不同最佳矫正视力(BCVA)水平的RP患者微视野检查参数的访内和访间TRV以及重复性系数(CoRs)。

方法

在这项单中心前瞻性队列研究中,对RP患者进行了两次评估,间隔14.0天。患者按BCVA分组:低视力(≤20/50 Snellen;≥0.4 logMAR)或中度视力(>20/50 Snellen;<0.4 logMAR)。使用Bland-Altman分析,确定中视微视野检查中逐点(dB)、平均(dB)和体积敏感度(dB*deg)的访内和访间变异性的CoRs。

结果

低视力组(n = 32)平均、体积和逐点敏感度的访内CoRs分别为1.7 dB、353.2 dBdeg和8.6 dB,中度视力组(n = 15)分别为0.9 dB、254.5 dBdeg和7.3 dB。低视力组(n = 31)平均、体积和逐点敏感度的访间CoRs分别为2.4 dB、355.2 dBdeg和10.2 dB。中度视力组(n = 16)平均、体积和逐点敏感度的CoRs较小,分别为1.6 dB、386.8 dBdeg和7.7 dB。BCVA和平均敏感度是体积敏感度TRV的预测因素,但注视稳定性不是。

结论

由于显著的TRV,无论BCVA如何,逐点敏感度对于RP患者来说都是不可靠的终点。当BCVA相对保留时,平均敏感度适合作为终点。体积敏感度提供了额外的空间信息,并有望作为评估RP患者中视微视野检查黄斑敏感度变化的临床终点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197a/11986405/0cdef2988ede/AOS-103-313-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197a/11986405/04beafaca280/AOS-103-313-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197a/11986405/23def332242b/AOS-103-313-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197a/11986405/3d0cb464ff25/AOS-103-313-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197a/11986405/42a54c689621/AOS-103-313-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197a/11986405/53b2eefe9453/AOS-103-313-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197a/11986405/1c73db38c7b8/AOS-103-313-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197a/11986405/0cdef2988ede/AOS-103-313-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197a/11986405/04beafaca280/AOS-103-313-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197a/11986405/23def332242b/AOS-103-313-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197a/11986405/3d0cb464ff25/AOS-103-313-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197a/11986405/42a54c689621/AOS-103-313-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197a/11986405/53b2eefe9453/AOS-103-313-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197a/11986405/1c73db38c7b8/AOS-103-313-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/197a/11986405/0cdef2988ede/AOS-103-313-g003.jpg

相似文献

1
Test-retest variability of mesopic microperimetry-associated parameters in patients with retinitis pigmentosa: REPEAT Study Report No. 2.视网膜色素变性患者中明视微视野相关参数的重测变异性:重复研究报告第2号。
Acta Ophthalmol. 2025 May;103(3):313-326. doi: 10.1111/aos.16780. Epub 2024 Nov 24.
2
Reliability of Mesopic Measures of Visual Acuity and Contrast Sensitivity and Their Correlation with Rod and Cone Function in Retinitis Pigmentosa.视网膜色素变性的明视和对比敏感度中间值测量的可靠性及其与视杆和视锥功能的相关性。
Ophthalmic Res. 2020;63(2):133-140. doi: 10.1159/000503931. Epub 2019 Dec 5.
3
Correlations between the Michigan Retinal Degeneration Questionnaire and visual function parameters in patients with retinitis pigmentosa.密歇根视网膜变性问卷与色素性视网膜炎患者视觉功能参数的相关性。
Acta Ophthalmol. 2024 Aug;102(5):555-563. doi: 10.1111/aos.16601. Epub 2023 Dec 29.
4
Microperimetry as an Outcome Measure in RPGR-associated Retinitis Pigmentosa Clinical Trials.微视野计作为 RPGR 相关性视锥细胞营养不良临床试验的一种结局测量方法。
Transl Vis Sci Technol. 2023 Jun 1;12(6):4. doi: 10.1167/tvst.12.6.4.
5
Retest Reliability of Mesopic and Dark-Adapted Microperimetry in Patients With Intermediate Age-Related Macular Degeneration and Age-Matched Controls.复测中间型年龄相关性黄斑变性患者与年龄匹配对照者的明适应和暗适应微视野计的复测可靠性。
Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD152-AMD159. doi: 10.1167/iovs.18-23878.
6
Visual loss and perimetric sensitivity in eyes with retinitis pigmentosa.视网膜色素变性患者的视力丧失和视野敏感性。
Jpn J Ophthalmol. 2013 Nov;57(6):563-7. doi: 10.1007/s10384-013-0271-7. Epub 2013 Aug 23.
7
Retinal light sensitivity as outcome measure in recessive Stargardt disease.视网膜光敏感度作为隐性斯塔加特病的结局测量指标。
Br J Ophthalmol. 2021 Feb;105(2):258-264. doi: 10.1136/bjophthalmol-2020-316201. Epub 2020 Apr 28.
8
THREE-DIMENSIONAL HILL OF VISION OF RETINAL SENSITIVITY IN PARTICIPANTS WITH X-LINKED RETINITIS PIGMENTOSA UNDER SCOTOPIC AND MESOPIC CONDITIONS.X连锁视网膜色素变性患者在暗视和中间视觉条件下视网膜敏感度的三维视觉山丘
Retina. 2025 Jan 1;45(1):7-13. doi: 10.1097/IAE.0000000000004278.
9
Test-Retest Reliability of Scotopic and Mesopic Fundus-Controlled Perimetry Using a Modified MAIA (Macular Integrity Assessment) in Normal Eyes.正常眼使用改良MAIA(黄斑完整性评估)进行暗适应和中间视觉眼底控制视野检查的重测信度
Ophthalmologica. 2017;237(1):42-54. doi: 10.1159/000453079. Epub 2016 Dec 21.
10
Visual field indices and patterns of visual field deficits in mesopic and dark-adapted two-colour fundus-controlled perimetry in macular diseases.在黄斑疾病的中间光和暗适应双色眼底控制视野检查中,视野指数和视野缺损模式。
Br J Ophthalmol. 2018 Aug;102(8):1054-1059. doi: 10.1136/bjophthalmol-2017-311012. Epub 2017 Nov 16.

引用本文的文献

1
Artificial intelligence-quantified schisis volume as a structural endpoint for gene therapy clinical trials in X-linked retinoschisis.人工智能量化的视网膜劈裂体积作为X连锁视网膜劈裂症基因治疗临床试验的结构终点。
Acta Ophthalmol. 2025 Sep;103(6):715-724. doi: 10.1111/aos.17485. Epub 2025 Mar 29.

本文引用的文献

1
Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study.XIRIUS 随机 2/3 期研究中 Cotoretigene Toliparvovec 治疗 X 连锁性视网膜炎的视觉功能评估。
Ophthalmology. 2024 Sep;131(9):1083-1093. doi: 10.1016/j.ophtha.2024.02.023. Epub 2024 Feb 28.
2
Microperimetry as an Outcome Measure in RPGR-associated Retinitis Pigmentosa Clinical Trials.微视野计作为 RPGR 相关性视锥细胞营养不良临床试验的一种结局测量方法。
Transl Vis Sci Technol. 2023 Jun 1;12(6):4. doi: 10.1167/tvst.12.6.4.
3
Microperimetry Reliability Assessed From Fixation Performance.
从固视性能评估微视野计的可靠性。
Transl Vis Sci Technol. 2023 May 1;12(5):21. doi: 10.1167/tvst.12.5.21.
4
Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations.与 RPGR 基因突变相关的 X 连锁性视网膜炎的 Cotoretigene Toliparvovec 治疗后视网膜敏感性的变化。
JAMA Ophthalmol. 2023 Mar 1;141(3):275-283. doi: 10.1001/jamaophthalmol.2022.6254.
5
Therapy with voretigene neparvovec. How to measure success?伏瑞替戈尼静脉输注治疗。如何衡量疗效?
Prog Retin Eye Res. 2023 Jan;92:101115. doi: 10.1016/j.preteyeres.2022.101115. Epub 2022 Sep 10.
6
CRB1-Associated Retinal Dystrophies: A Prospective Natural History Study in Anticipation of Future Clinical Trials.CRB1 相关视网膜营养不良:未来临床试验预期的前瞻性自然病史研究。
Am J Ophthalmol. 2022 Feb;234:37-48. doi: 10.1016/j.ajo.2021.07.021. Epub 2021 Jul 25.
7
Characterization of Retinal Function Using Microperimetry-Derived Metrics in Both Adults and Children With RPGR-Associated Retinopathy.使用微视野衍生指标对 RPGR 相关性视网膜病变的成人和儿童的视网膜功能进行特征描述。
Am J Ophthalmol. 2022 Feb;234:81-90. doi: 10.1016/j.ajo.2021.07.018. Epub 2021 Jul 22.
8
Microperimetry Hill of Vision and Volumetric Measures of Retinal Sensitivity.视野 Hill 图和视网膜敏感度的容积测量
Transl Vis Sci Technol. 2021 Jun 1;10(7):12. doi: 10.1167/tvst.10.7.12.
9
Clinical Perspectives and Trends: Microperimetry as a Trial Endpoint in Retinal Disease.临床观点与趋势:微视野计在视网膜疾病中的试验终点应用。
Ophthalmologica. 2021;244(5):418-450. doi: 10.1159/000515148. Epub 2021 Feb 10.
10
Defining inclusion criteria and endpoints for clinical trials: a prospective cross-sectional study in CRB1-associated retinal dystrophies.定义临床试验的纳入标准和终点:CRB1 相关视网膜营养不良的前瞻性横断面研究。
Acta Ophthalmol. 2021 May;99(3):e402-e414. doi: 10.1111/aos.14597. Epub 2021 Feb 2.